| [2] Hoskin PJ，Hanks GW.Opioid agonist-antagonist drugs in acuteand chronic pain states[J].Drugs，1991，41(3) : 326 - 344. | |
| [2] | 岳修勤.地佐辛与芬太尼用于术后静脉镇痛的临床效果比较[J].中国疼痛医学杂志，2010，16(4) : 255 - 256. |
| [3] 庄心良，曾因明，陈伯銮.现代麻醉学[M].3 版.北京: 人民卫生出版社，2003: 514 - 515. | |
| [4] Fischer BD，Dykstra LA.Interactions between an N-methly-Dasparteantagonist and low-efficacy opioid receptor agonists inassays of schedule-controlled Responding And Thermal nociceptionExp[J].J Pharmacol Ther，2006，318(3) : 1300 - 1306. | |
| [5] Fukuda K.Opioids [M]//Miller RD.Anesthesia.7th ed.Philadelphia: Churchill Livingstone，2010: 769 - 824. | |
| [6] Prasad Verma PR，Chandak AR.Development of matrix controlledtransdermal delivery systems of pentazocine: in vitro/in vivoperformance[J].Acta Pharm，2009，59(20) : 171 - 186. | |
| [7] 邱小弟，余守章，黄焕林.喷他佐辛临床镇痛的应用研究进展[J].广东医学，2010，31(10) : 1218 - 1220. |